Current Clinical Aspects of Androgen Deprivation Therapy for Locally Advanced and Metastatic Prostate Cancer: A Scoping Review for Urologists and Medical Providers.

22 Lastly, the analysis of non-PCa mortality favored iADT over cADT as a trend, though it did not quite reach statistical significance. 22 Though iADT is typically not initiated at the start of PCa treatment, it is typically considered appropriate to be deployed 9–12 months into treatment of traditional ADT or until PSA nadir has been reached, ideally reaching PSA < 0.1 ng/mL.

also in 679 other papers